United States News Todas as matérias

Stereotaxis (NYSE:STXS), a global leader in endovascular surgical robotics, announced on Tuesday, January 6, 2026, that it has received U.S. Food and Drug Administration (FDA) approval for its MAGiC™ Magnetic Interventional Ablation Catheter.

TransCode Therapeutics (NASDAQ:RNAZ) today announced positive preclinical data demonstrating that its lead candidate, TTX-MC138, successfully reaches orthotopic glioblastoma tumors following intravenous administration and achieves sustained target engagement against miR-10b.

Lockheed Martin (NYSE:LMT) announced a transformative seven-year framework agreement with the U.S. Department of War on January 6, 2026.

The deal is designed to more than triple the annual production capacity of the PAC-3® Missile Segment Enhancement (MSE) interceptor, surging from current levels of approximately 600 units to a target of 2,000 units per year.

The agreement is a flagship outcome of the Department of War’s new Acquisition Transformation Strategy.

By providing long-term "demand certainty," the framework incentivizes Lockheed Martin and its massive global supply chain to invest in expanded tooling, facilities, and workforce.

To manage the financial burden of such a rapid scale-up, the deal utilizes a "collaborative financing model" that aims for cash neutrality in the early stages, allowing Lockheed to fund the expansion without immediate pressure on its balance sheet.

This "surging" of the "Arsenal of Freedom" follows a record-breaking 2025, where Lockheed Martin delivered 620 PAC-3 MSEs—a 20% year-over-year increase.

The PAC-3 MSE is a "hit-to-kill" interceptor, meaning it uses pure kinetic energy rather than a blast-fragmentation warhead to neutralize threats, making it the premier defense against advanced ballistic missiles, cruise missiles, and emerging hypersonic threats.

Profound Medical Corp. (NASDAQ:PROF) on Tuesday announced that Johns Hopkins Hospital has performed its first commercial prostate cancer treatment using the company's TULSA-PRO system, marking a key adoption milestone for the MRI-guided, incision-free ablation technology.

Bright Minds Biosciences (NASDAQ:DRUG) shares are under the spotlight following the announcement of "positive and significant" topline results from its Phase 2 BREAKTHROUGH study.

Alkermes (NASDAQ:ALKS) announced on January 6, 2026, that the U.S. FDA has granted Breakthrough Therapy Designation to alixorexton (formerly ALKS 2680) for the treatment of narcolepsy type 1 (NT1).

Sunoco LP (NYSE:SUN) issued its 2026 financial guidance on Tuesday, January 6, 2026, projecting a robust leap in earnings following a year of massive consolidation.

The partnership expects full-year adjusted EBITDA to land between $3.1 billion and $3.3 billion, a range that reflects the full integration of the Parkland acquisition and the upcoming close of the TanQuid terminal deal in Europe.

Ryder System (NYSE:R) announced the successful acquisition of Truck Service Depot, an Atlanta-based mobile maintenance firm, on January 5, 2026.

The move is a strategic bolt-on for Torque by Ryder™, the company’s rapidly expanding retail mobile maintenance division, as it seeks to capture a larger share of the on-demand fleet service market in the Southeast.

McEwen Mining (NYSE:MUX) and Canadian Gold Corp. completed their statutory plan of arrangement effective January 5, 2026, officially consolidating the high-grade Tartan Gold Mine into McEwen’s portfolio.

The merger, finalized at 8:00 a.m. Vancouver time, marks a strategic expansion for McEwen as it targets a doubling of its total production by 2030.

Apogee Therapeutics (NASDAQ:APGE) shares are trending today after the company reported positive interim Phase 1b results for zumilokibart (APG777), its half-life extended anti-IL-13 antibody.

Aclarion (NASDAQ:ACON) reached a significant clinical milestone on Tuesday, January 6, 2026, announcing the first patient enrollments at two prestigious new sites: Northwestern Medicine and Scripps Health.

This expansion brings the total number of active enrollment sites to four, with seven leading U.S. spine centers having completed full regulatory and operational setup.

Radware (NASDAQ:RDWR) announced Tuesday, January 6, 2026, that it has doubled its global cloud security mitigation capacity, jumping from 15 Tbps to 30 Tbps.

The massive upgrade comes in response to a "seismic shift" in the threat landscape, headlined by an 85% surge in network DDoS attacks during the first half of 2025.

Lithium Argentina AG (NYSE:LAR) shares are in focus after the company announced standout preliminary 2025 results for its Cauchari-Olaroz operation.

The project, a joint venture with Ganfeng Lithium, achieved full-year production of 34,100 tonnes of lithium carbonate—reaching the upper limit of its 30,000–35,000 tonne guidance.

AngioDynamics (NASDAQ:ANGO) on Tuesday reported fiscal second-quarter results that highlighted continued momentum in its high-margin Med Tech portfolio, with overall net sales rising 8.8% year over year to $79.4 million for the period ended Nov. 30, 2025.

Accenture (NYSE:ACN) has agreed to acquire Faculty, a prominent U.K.-based AI services and products firm, in a move that signals a major escalation in the global consulting giant's push toward "applied AI."

Himax Technologies (NASDAQ:HIMX) and Vuzix Corporation (NASDAQ:VUZI) have jointly introduced a new optical reference design for augmented reality (AR) glasses, marking a major step toward making smart eyewear as wearable as traditional frames.

Oculis Holding AG (NASDAQ:OCS) shares climbed today after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to Privosegtor (OCS-05), a first-in-class neuroprotective candidate for the treatment of optic neuritis.

The designation, announced January 6, 2026, marks a major milestone for the Swiss biotech as it targets a $7 billion U.S. market for optic neuropathies.

Calumet (NASDAQ:CLMT) released a preliminary fiscal 2025 update on Tuesday, signaling a major turning point in its effort to repair a stretched balance sheet.

Despite projecting a net loss between $69 million and $12 million, the Indianapolis-based specialty products maker highlighted a significant reduction in restricted debt and a "transformed" outlook for its high-growth renewable energy subsidiary.

Natera (NASDAQ:NTRA) announced a significant clinical breakthrough today, revealing that its pivotal Phase III ALTAIR trial successfully reached statistical significance following a reclassification of patient data.

Broadridge Financial Solutions (NYSE:BR) has completed its acquisition of Acolin, a Zurich-based leader in cross-border fund distribution and regulatory services.

The deal, finalized on January 6, 2026, significantly bolsters Broadridge’s footprint in the European asset management market and integrates specialized compliance technology into its global fintech stable.

Hyundai plans to roll out human-like robots across its factories as global manufacturers race to adopt automation.

Chrystia Freeland is leaving Canada’s parliament to take on an advisory role with Ukraine’s president.

Nvidia’s chief executive says AI growth is fuelling a sharp surge in global demand for computing resources.

Bill Miller IV and other analysts say Bitcoin is showing signs of renewed strength amid regulatory and institutional support.